Cardiovascular risk reduction is the highest-growth established indication in the GLP-1 market at 22.7% CAGR as SELECT trial outcomes transform prescribing beyond endocrinology into cardiology channels
It slows gastric emptying, enhances satiety, and reduces hunger, leading to a lower caloric intake
Five compounders and distributors interviewed for this article said they conduct due diligence on every lot of semaglutide or tirzepatide they buy or produce, upholding standards of purity, sterility, and consistency similar to those practiced in the commercial drug industry
You draw the right amount every time, and resources like the semaglutide dosage calculator can double-check your work before you inject
Menardo J, Tang Y, Ladrech S, Lenoir M, Casas F, Michel C, Bourien J, Ruel J, Rebillard G, Maurice T, Puel JL, Wang J